Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Articles
Level of cost sharing faced by patients with cancer
By
Michael Kolodziej, MD
Videos
In this segment Dr. Kolodziej explains how we ask patients to participate in a value based fashion can be a really tricky.
Read More
Oncologists and Cost Issues
By
Michael Kolodziej, MD
Videos
In this video Dr. Kolodziej talks about how the role of the Oncologist and cost issues.
Read More
Will Accountable Care organizations have a positive impact on oncology and patients with cancer
By
Michael Kolodziej, MD
Accountable Care Organization
Videos
Dr. Michael Kolodziej explains how ACO's ability to improve cancer care is still unclear.
Read More
Safety Overview of the CLLM1 Trial: Lenalidomide Maintenance Therapy After Frontline Chemoimmunotherapy in High-Risk CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Functional Evidence that Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
The Combination of Alemtuzumab and Ofatumumab in Previously Untreated CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Ublituximab plus TGR-1202 in Heavily Pretreated and High-Risk CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Ibrutinib in Relapsed/Refractory CLL After Allogeneic Stem-Cell Transplant
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Dinaciclib plus Ofatumumab in Patients with Relapsed/Refractory CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Ibrutinib versus Ofatumumab in Patients with Relapsed/Refractory CLL in the RESONATE Study
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
Read More
Page 205 of 329
202
203
204
205
206
207
208
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma